JENNIFER WILLIS: Open Payments
NPI 1447924170 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 24 payments from 15 companies in 2025. Trend: 2023 $498 · 2024 $1,110 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| PFIZER INC. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Lilly USA, LLC | 2 | $32 |
| Boston Scientific Corporation | 1 | $31 |
| Novo Nordisk Inc | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: XIFAXAN, VRAYLAR, LEQVIO, CAPVAXIVE, MOUNJARO, General - DBS, ELIQUIS, GEMTESA.
Industry payments across PA — which companies pay providers there.
